Share

Interview with Winette van der Graaf: enhanced patient participation in trials may help make cancer research more heterogeneous

ESMO Congress 2022. Winette van der Graaf, president of EORTC, talks about the importance and challenges of placing the patient at the center of clinical trials. She states that patients are usually highly motivated to participate in clinical trials. However, several challenges, such as logistics, communication issues, and geographic distance to a trial center, may prevent them from doing so. Moreover, the current strict enrolment criteria often exclude older patients from clinical trials. The result is that trials tend to be overly homogeneous, thus limiting the generalisability of the data. With an aging population, we need more elderly patients to participate in clinical trials. Read the full article here.

Back to news list

Related News

  • EORTC Quality of Life Group celebrating 40 years

  • Results of two EORTC studies have been published in NEJM and the Lancet Oncology

  • New results, updates, and forthcoming EORTC trials in melanoma, soft tissue sarcoma, head and neck, testicular and lung cancer presented at ESMO 2022

  • Important new data from EORTC trials to be presented at ESMO 2022

  • EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds

  • EORTC Completes Patient Recruitment to Study of Treatment for unresectable or metastatic melanoma

  • In Memoriam: Dr Martin Charles Mihm

  • The 1500th patient has been enrolled in the E²-RADIatE cohort OLIGOCARE (RP-1822)

  • PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Long-term follow-up of chemoradiotherapy treatment in glioma patients shows significantly increased survival